About
Progentec Diagnostics develops proteomics-based blood biomarker tests and digital health tools to monitor and proactively manage autoimmune diseases such as systemic lupus erythematosus and multiple sclerosis.
Explore Progentec Diagnostics, Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.